18–23 Sept 2011
Città del Mare, Terrasini - Palermo - Sicily - Italy
Europe/Rome timezone
3rd International Nuclear Chemistry Congress - 3rd-INCC

Session

Session 7

7
20 Sept 2011, 11:40
Città del Mare, Terrasini - Palermo - Sicily - Italy

Città del Mare, Terrasini - Palermo - Sicily - Italy

Presentation materials

There are no materials yet.

  1. Dr Rolf Zeisler (NIST)
    20/09/2011, 11:40
    Radiopharmaceuticals Chemistry
    oral presentation
    The 2010 Topical Meeting on Isotopes for Medicine and Industry, the second in a new series of embedded topical meeting of the American Nuclear Society (ANS), was held at the Society’s Winter Meeting, Las Vegas, NV, November 7 – 11, 2010. The meeting series reflects the continuing growth of radioisotopes for both medical and industrial applications and the rapidly expanding research at this...
    Go to contribution page
  2. Dr Ugur Avcibasi (1)
    20/09/2011, 12:00
    Radiopharmaceuticals Chemistry
    oral presentation
    BLM isolated from the fermentation products of Streptomyces verticillus in 1966 by Umezawa in Japan belongs to a family of structurally related small glycopeptides (1 kDa) that give rise to single-stranded DNA breaks and DNA double-strand breaks (DSBs) in a metal- and oxygen dependent manner1. The BLM used clinically is a mixture of three distinct isomers, A2 (the most abundant, 65 %), B2...
    Go to contribution page
  3. Mrs Gülcan Ünak (Ege University, Faculty of Science, Department of Biochemistry)
    20/09/2011, 12:15
    Radiopharmaceuticals Chemistry
    oral presentation
    2-Fluoro-2-deoxy-D-glucose radiolabeled with Fluorine-18 (18F-FDG) is routinely used in nuclear medicine as a PET imaging radiopharmaceutical and nucleophilicly synthesised, in general, using mannose triflate as a precursor in the presence of Kryptofix 222TM as a catalyst in acetonitrile as a polar aprotic solvent, which involves the SN2 nucleophilic substitution reaction of 18F to 2-position...
    Go to contribution page
  4. Dr Stanislav Pavelka (1Department of Radiometry, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague and 2Central-European Technology Institute, Masaryk University, Brno, Czech Republic)
    20/09/2011, 12:30
    Radiopharmaceuticals Chemistry
    oral presentation
    Using [I-125]-labeled iodothyronines as substrates, we applied our newly developed radiometric enzyme assays for iodothyronine deiodinases (IDs) of types 1, 2 and 3 (D1, D2 and D3), as well as the adapted radiometric assays for conjugating enzymes uridine 5’-diphospho-glucuronyltransferase (UDP-GT) and iodothyronine sulfotransferases (ST), in radiopharmacological studies of the interaction of...
    Go to contribution page
Building timetable...